Related Topics News -

     
 Detail   |   Print    Next page > 
     
《大行》瑞銀:藥明康德發行零息可換股債券輕微利好 反映管理層經營信心
2026-05-15T  
藥明康德擬發67.8億人幣可轉換債
2026-05-15T  
《大行》大摩:亞洲準備好捕捉全球AI資本支出激增機遇 列出區內最新主題焦點股名單
2026-05-14T  
《新股》丹諾醫藥今起招股一手入場費3,823.17元 藥明康德參與前期投資
2026-05-14T  
《大行》摩通:醫保目錄調整加速創新藥商業化 首選信達生物藥明康德藥明合聯科倫博泰
2026-05-12T  
《大行》高盛列出亞太區「確信買入」精選版股票名單(表)
2026-05-05T  
《大行》摩通:美眾議員要求FDA拒絕考慮中國生成臨床數據未寫入撥款法案 建議投資者不要立即採取行動
2026-05-05T  
《大行》大摩:美國擬禁藥企申請臨床試驗時使用中國數據 對外授權交易不受影響
2026-05-04T  
《大行》花旗:美國禁採納中國臨床試驗數據提案通過可能性低
2026-05-04T  
美國會提案禁採納中國臨床數據
2026-05-04T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.